A Study of ITC-6146RO in Patients With Advanced or Metastatic Cancer Who Have Failed Standard Therapy

Clinical trial NCT07423117 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07423117
Sponsor: IntoCell, Inc
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Castration-resistant Prostate Cancer Non-small Cell Lung Cancer Triple Negative Breast Cancer Metastatic Solid Tumor

Start date: 2026-02-06
Primary completion: 2027-06-30
Enrollment: 102

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.